arrow
I

Inger Marie Løes

Haukeland University Hospital
H指数:15
被引数:923

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study
2024-11-090
PRE
Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study
2024-10-081
PRE
Hepatectomy v°ersus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study
2024-07-250
PRE
Demystifying BRAF Mutation Status in Colorectal Liver Metastases A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions

揭示结直肠肝转移中BRAF突变状态的多机构,协作方法解决6个开放性临床问题

2022-12-0112
PRE
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases
2022-08-1024
OA
KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations
2022-05-207
OA
Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?
2021-10-205
OA
Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scores
2021-04-2411
PREAI
The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status A Study By the International Genetic Consortium for Colorectal Liver Metastasis
2019-08-0534
PREAI
Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases A Multi-institutional, International Analysis of 1099 Patients
2019-06-0181
PREAI
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
2018-07-18164
OAAI